A variety of algorithms and nomograms that calculate the probabilities of BCR-free survival after treatment have been used in order to direct clinicians into the most suitable treatment options for PCa patients [25]; nonetheless patients still present unforeseen disease course patterns. The gene discussed is BCR; the disease is posterior cortical atrophy.